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Introduction:  Currently, majority orthopaedic prosthesis and 
biomaterial researches have been based on investigation in normal 
animals. In most clinical situations, most patients do not have a normal 
bone quality that in many cases are due to osteoporosis (OP) even in 
osteoarthritic joints. Although a variety of ovariectomized (OVX) 
animals has been used to study osteoporosis, there is a great need for 
suitable large animal models with adequate bone size that closely 
resemble osteoporosis in humans.  
This study aimed to validate glucocorticoid-induced 
osteopenia sheep model for orthopaedic implant and biomaterial 
research. We hypothesized that a 7-month GC treatment together with 
restricted diet but without OVX would induce osteopenia.  
Materials and Methods: Eighteen female sheep were randomly 
allocated into 3 groups: group 1 (GC-1) received GC treatment (0.60 
mg/kg/day methylprednisolone) for 7 months, group 2 (GC-2) received 
the same treatment for 7 months, and further observed for 3 months 
without GC; and group 3 served as the control group, and left untreated 
for 7 months. The sheep were housed outdoors in paddocks, and 
received restricted diet with low calcium and phosphorus (0.55% 
calcium and 0.35% phosphorus) and hay.  
After sacrifice, cancellous bone specimens from the 5th 
lumbar vertebra, bilateral distal femur, and bilateral proximal tibia, and 
cortical bone samples from midshaft femur were micro-CT scanned 
(vivaCT 40, Scanco Medical AG., Switzerland) to quantify their 3-D 
microarchitectural properties(2). The cancellous bone samples were then 
tested compressively (MTS Systems Co., USA), and cortical bone 
samples after demineralized were tested in tensile to determine their 
mechanical properties. Serum biomarkers for bone formation 
(osteocalcin) and resorption (crosslaps) were determined. The results 
were analyzed statistically, and p<0.05 was considered significant.  
Results:  After 7 months of GC treatment, vertebral cancellous bone 
volume fraction was reduced by 36%, trabecular thickness by 30%, and 
changed from typical plate structure to a combination of plate and rod 
structure. A similar trend was also observed in the distal femur and 
proximal tibia of both GC treated sheep. The strength of vertebral 
cancellous bone was significantly reduced (Figs 1 & 2). The porosity of 
GC-2 femur midshaft cortical bone was significantly increased, while 
the tensile properties of cortical bone did not reveal significant change 
between the 3 groups (Figs 1 & 2). The serum osteocalcin, was reduced 
by 70%, but recovered with an increase of 45% at 10 month in the GC-2 
group (Fig 2). At 10 months, the GC-2 group had microarchitectural and 
mechanical properties similar to the level of the control sheep.  
Discussion:  The present study evaluated the effects of GC-treatment 
alone on the development of the microarchitecture and mechanical 
properties of the cancellous bone and cortical bone. The dose used 
corresponds to concentrations in earlier experimental studies, however in 
combination with OVX(1).  
Our data demonstrated the GC treatment affects cancellous 
bone and cortical bone. 7 month GC-treatment on density and 
microarchitecture of cancellous bone are comparable with those 
observed in human after long-term GC-treatment. Moreover, we have 
shown that bone strength and microarchitecture of cancellous bone 
recover after 3 months further observation without GC. Osteocalcin was 
significantly reduced after 7 months but a rebound phenomenon was 
observed after 10 months. This suggests that a prolonged administration 
of GC is needed for a long-term observation to keep osteopenic bone. 
 In conclusion, after 7 months of GC treatments with 
restricted diet, the microarchitectural characteristics, mechanical 
competence, mineralization of the bone tissues, and suppression of bone 
formation markers were similar to osteoporosis-related changes in 
humans. A prolonged GC treatment is needed for a long-term 
observation to keep osteopenic bone. This model resembles long-term 
GC treated OP model, and might be useful in pre-clinical studies.  
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Fig. 1. 3-D reconstruction of cancellous bone (upper) and midshaft 
cortical bone (lower). Significant changes in cancellous bone were seen. 
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Fig. 2. Microarchitectural & mechanical properties of sheep vertebral 
cancellous bone & femur midshaft cortical bone, and serum biomarkers. 
Data are presented as mean (SD). Significant differences are indicated.  
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